Evolutionary links between cytochrome P450 monooxygenases, a superfamily of extraordinarily divergent heme-thiolate proteins catalyzing a wide array of NADPH/NADH-and O 2 -dependent reactions, are becoming better understood because of availability of an increasing number of fully sequenced genomes. Among other reactions, P450s catalyze the site-specific oxidation of the precursors to macrolide antibiotics in the genus Streptomyces introducing regiochemical diversity into the macrolide ring system, thereby significantly increasing antibiotic activity. Developing effective uses for Streptomyces enzymes in biosynthetic processes and bioremediation requires identification and engineering of additional monooxygenases with activities toward a diverse array of small molecules. To elucidate the molecular basis for substrate specificity of oxidative enzymes toward macrolide antibiotics, the x-ray structure of CYP154C1 from Streptomyces coelicolor A3(2) was determined (Protein Data Bank code 1GWI). Relocation of certain common P450 secondary structure elements, along with a novel structural feature involving an additional ␤-strand transforming the five-stranded ␤-sheet into a six-stranded variant, creates an open cleft-shaped substrate-binding site between the two P450 domains. High sequence similarity to macrolide monooxygenases from other microbial species translates into catalytic activity of CYP154C1 toward both 12-and 14-membered ring macrolactones in vitro.
The post-genomic era opens new opportunities for structural insight into the evolution of a single protein family within and between species. Cytochrome P450 (CYP) 1 monooxygenases are a superfamily of heme-thiolate enzymes that are involved in a wide array of NADPH/NADH-and O 2 -dependent reactions (1) . There are currently more than 2000 family members, including a large number of putative P450 open reading frames found in fully sequenced prokaryotic and eukaryotic genomes (drnelson. utmem.edu/CytochromeP450.html). Extensive studies have firmly established their role in the biosynthesis of sterols, fatty acids, and prostaglandins in animals, antibiotics, and other biologically active molecules in bacteria, fungi, and plants as well as in the metabolism of xenobiotic drugs and toxic chemicals (2). Accordingly, the extraordinary diversity in amino acid sequence enables wide variation in the substrates utilized and the patterns of oxidation catalyzed by these enzymes. A particularly rich source of CYPs is from Streptomyces spp., a group of developmentally complex, Gram-positive bacteria that are known for production of a broad array of biologically active secondary metabolites. Streptomyces coelicolor A3(2) has been investigated extensively as a model system for the study of morphological and physiological development of Streptomyces and for investigation of the genetic control of antibiotic production (3) . Over the past decade, an increasing number of Streptomyces spp. have been investigated because of their production of pharmaceutically important compounds including anti-cancer agents, immunosuppressants, and antibiotics. In addition, Streptomyces are being recognized as a source of versatile biocatalysts for the detoxification of hazardous chemicals (4 -9) in bioremediation processes.
In an effort to analyze fully the complement of CYPs in the industrially important Streptomyces, we decided to focus on the 8.7 Mb S. coelicolor A3(2) genome whose sequence was recently completed by the Sanger Centre (10) (www.sanger.ac.uk/ Projects/S_coelicolor/). Although 18 CYP open reading frames are found dispersed throughout the S. coelicolor A3(2) chromosome (10, 11) , the functions of the corresponding gene products and their role in various metabolic functions remain largely undefined.
Most of the currently identified antibiotics are produced by complex biosynthetic systems comprised of clustered gene sets located contiguously on the Streptomyces chromosome (12) (13) (14) (15) (16) (17) (18) . The clustering of secondary metabolite genes has been an aid in the isolation of P450 monooxygenases involved in antibiotic biosynthesis. Cytochrome P450 monooxygenases are particularly common in polyketide biosynthetic gene clusters, and they catalyze site-specific tailoring reactions leading to the macrolide antibiotics, including methymycin, neomethymycin, and pikromycin (12, 19 -22) , novamethymycin (23), oleandomycin (24) , amphotericin (17) , and erythromycin (25, 26 ally, CYPs are involved in the formation of the anticancer agent epothilone (27, 28) , immunosuppressant rapamycin (29, 30) , the growth promoter tylosin (14) , and the antiparasitic agent avermectin (15) . These reactions typically occur during the late stages of biosynthesis after formation of the core ring system by a polyketide synthase. The hydroxyl or epoxide substituents provide an important layer of structural variability into the final natural product structures and often significantly influence biological activity (12, 22) . P450 monooxygenases are also involved in one of the initial steps in formation of the coumarin group of antibiotics (31) , and of the peptidyl nucleoside antibiotic nikkomycin (32) , as well as in oxidative tailoring of the vancomycin-like glycopeptides balhimycin (16) and complestatin (33) . Ultimately, the power to manipulate macrolide metabolic systems using combinatorial biosynthetic technology (34 -36) will be extended by identification and/or engineering of additional monooxygenases with versatile activities to provide novel biologically active natural products.
Our current study was motivated by the intriguing amino acid sequence relationship between a number of S. coelicolor A3(2) CYPs that show significant similarity with P450 monooxygenases from other microorganisms involved in regiospecific oxidation of macrolide antibiotics. Among eight crystal structures reported for cytochrome P450 over the last 17 years, only one has been reported for a macrolide hydroxylase (P450 EryF from Saccharopolyspora erythraea) (37) . EryF is involved in hydroxylation of C-6 of the 14-membered ring macrolactone 6-deoxyerythronolide B in the erythromycin biosynthetic pathway. To elucidate structural, functional, and evolutionary aspects of monooxygenases that tailor macrolide and xenobiotic molecules, crystallographic analysis of the cytochrome P450 complement of S. coelicolor A3(2) (10, 11) was initiated. We report here the first structural and functional analysis of the monooxygenase CYP154C1 from this organism determined to 1.92 Å resolution.
EXPERIMENTAL PROCEDURES
CYP154C1 Purification-The DNA sequence corresponding to CYP154C1 with four histidine codons inserted at the 3Ј end was generated by PCR and cloned into the Escherichia coli expression vector pET17b as described elsewhere (11) . The protein was expressed in HMS174(DE3) cells (Novagen) and purified to homogeneity by nickelnitrilotriacetic acid (Qiagen) and Q-Sepharose (Amersham Biosciences) chromatography.
CYP154C1 Crystallization and Data Collection-Crystals grew in hanging drops from 0.4 mM CYP154C1 in 10 mM Tris-HCl, pH 7.5, 450 mM NaCl, 0.5 mM EDTA mixed with an equal volume of 1.6 M MgSO 4 , 100 mM MES, pH 6.5, 10 mM 2-methylimidazole at 22°C. Native diffraction data and multiple anomalous dispersion data at three wavelengths (Tables I-III) CYP154C1 Phasing and Refinement-The images were integrated, and the intensities were merged using HKL2000 (38) . The positions of two iron sites were determined with SnB (39) . The phases were calculated and improved by CNS (40) yielding an interpretable electron density map at 2.3 Å resolution. Crystallographic refinement was carried out with CNS (40) using native data to a resolution of 1.92 Å. The final atomic model (Tables I-III) with an R factor of 20.8% (22.8%) was obtained after iterations of refinement (CNS (40)), evaluation (PRO-CHECK (41)), and manual building (O (42)). Two protein molecules are present in the asymmetric unit. The quality of the final structure (Tables I-III) was assessed with the program PROCHECK (41) . For the first molecule, 90.1% of residues were found in the most-favored regions of the Ramachandran plot, and 9.9% were found in the allowed regions. For the second molecule, 91.7% of residues were found in the mostfavored regions of the Ramachandran plot, and 9.3% were found in the allowed regions.
Spectral Substrate and Inhibitor Binding Assays-YC-17-induced (43) and narbomycin-induced (44) spectral shifts were monitored at 23.5°C by using a Shimadzu UV-2401 spectrophotometer. The sample contained 1 ml of 5 M CYP154C1 in 10 mM Tris-HCl, pH 7.5, 10% glycerol. YC-17 and narbomycin were dissolved in ethanol at a stock concentration of 25 mM. Spectral binding assay was carried out by difference spectra with the addition of substrate dissolved in ethanol to the sample cuvette and ethanol to the reference cuvette by 2-l aliquots. The assays were performed by using eight YC-17 or narbomycin concentrations ranging from 50 to 390 M. The data were linearized in the form of the S 0 /⌬A versus S 0 plot, where S 0 is a total concentration of substrate in the reaction mixture. The difference in absorbance between 
where F o and F c are the observed and calculated structure factor amplitudes. R free is the same as R but calculated with using 10% of reflections omitted from the refinement.
c Program PROCHECK (41) . a Data for high resolution bins are listed in parentheses. b R sym ϭ ⌺ ͉ I i Ϫ ͗I͘ ͉ /⌺I i where I i is the intensity of the i th observation, and ͗I͘ is the mean intensity of reflection.
384 nm (peak) and 418 nm (trough) for each spectrum was taken as the ⌬A of the reaction. K d was estimated from the intercept of the linear plot on the S 0 axis. Catalytic Activity-The CYP154C1 and PikC conversion of YC17 or narbomycin was compared using a modification of the assay developed for PikC (19) . The assay mixture contained 1 M enzyme, 3.5 mM spinach ferredoxin, 0.1 unit of spinach ferredoxin-NADP ϩ reductase, 1 mM NADPH, and ϳ500 M YC17 or narbomycin in a total volume of 1 ml of conversion buffer (100 mM NaH 2 PO 4 , pH 7.3, 1 mM EDTA, 0.2 mM dithiothreitol, and 10% glycerol). The reaction was carried out at 37°C for 20 min and terminated by extraction with ethyl acetate (3 ϫ 1 ml) . The extracts were combined, dried, and resuspended in 100 l of ethyl acetate. The extracts were compared with purified compounds using silica TLC developed with chloroform:methanol:NH 4 OH (9:1:0.1) and stained with vanillin.
RESULTS AND DISCUSSION
Sequence Homology with Other Monooxygenases-CYP154C1 (Q9L142; accession numbers are according to SWISS-PROT/ TrEMBL Protein Knowledgebase, tw.expasy.org/sprot/) is one of the 18 cytochromes P450 revealed in the S. coelicolor A3 (2) genome (10), and one of the two assigned to the CYP154 family (11) . The closest homolog of CYP154C1 identified in the data base using program BLAST (45) is a cytochrome P450 CYP154B1 from Streptomyces fradiae with 44% sequence identity (Q9XCC6) localized within the tylosin biosynthetic gene cluster (13) . However, because macrolactone ring hydroxylations at C-20 and C-23 that occur during tylosin biosynthesis are catalyzed by the products of different genes, one of which encodes another cytochrome P450, CYP105L1 (Q9ZHQ1) (14) , the role of the CYP154C1 homolog in S. fradiae remains unknown. CYPs with lower identity include the second member of CYP154 family in S. coelicolor A3(2), CYP154A1 (Q9KZR7) (with 42% identity), as well as CYP107B1 (B42606) and EryF, or CYP107A1 (Q00441), from S. erythraea (both with 37% identity and 54 and 51% homology, respectively). There are also a number of P450s from different Streptomyces species having about 36% identity, including CYP107C1 from S. thermotolerans (Q60005), CYP107L1 (PikC) from Streptomyces venezuelae (O87605), PTED from Streptomyces avermitilis (Q93H80), and CYP107D1 (OLEP) from Streptomyces antibioticus (Q59819). This last group of related P450s is known to be involved in modification of macrolide antibiotics such as carbomycin (46) , methymycin, neomethymycin, pikromycin (19, 21, 22) , novamethymycin (23), avermectin (15) , and oleandomycin (24) .
Two S. erythraea enzymes, CYP107B1 and EryF (46% identical to each other) show the same level of identity to CYP154C1 from S. coelicolor A3(2) (Fig. 1) . Having 46% identity, the enzymes have different enzymatic activity. Specifically, EryF catalyzes C-6 hydroxylation of the 6-deoxyerythronolide B (Scheme 1) in the biosynthesis of erythromycin (47) . CYP107B1 shows no detectable activity toward 6-deoxyerythronolide B (48) , and its function remains unknown. Interestingly, CYP107B1 has 51% identity and 65% homology with the PikC from S. venezuelae (Fig. 1A) . Previous studies have revealed that PikC has remarkable substrate flexibility. It is capable of accepting 12-and 14-membered ring macrolides as substrates and catalyzes conversion of the 12-membered ring macrolide intermediate YC-17 to methymycin, neomethymycin (12, 19, 21) , and novamethymycin (23) . PikC also converts the 14-membered ring macrolide narbomycin to pikromycin (12, 19, 21, 22 (Fig. 1A) led us to investigate its catalytic activity toward these important compounds. Thus, the protein was tested against 12-and 14-membered ring macrolide intermediates YC-17 and narbomycin, which are converted to methymycin, neomethy-FIG. 1. Sequence alignment between CYP154C1 from S. coelicolor A3(2) and homologous P450 monooxygenases. A, sequence alignment between CYP154C1 from S. coelicolor A3(2), EryF (CYP107A1) from S. erythraea, and PikC from S. venezuelae. B, fragment of sequence alignment between CYP154C1 from S. coelicolor A3(2) and CYP105 proteins from S. griseus accession numbers for CYP105A1, B1, C1, and D1 in the SWISS-PROT data base are P18326, P18327, P23296, and P26911, respectively. The black shading shows regions of conservation, whereas gray shading denotes similarity of amino acid residues in a given position. Residue numbers for each protein correspond to their sequences deposited in the data base. Secondary structure elements are assigned based on crystal structures for CYP154C1 determined here and for EryF (Protein Data Bank code 1OXA). The ␣-and 3 10 mycin, novamethymycin, and pikromycin by PikC in S. venezuelae (12, 19 -23) (Scheme 1). Interestingly, CYP154C1 showed catalytic activity toward both substrates. The reaction with the 14-membered ring macrolide narbomycin was notably faster and resulted in a more complete conversion to pikromycin compared with conversion of the 12-membered ring macrolide, YC-17. However, transformation of YC-17 was accomplished with notable position selectivity at the C12 position, leading predominantly to neomethymycin. This substrate selectivity is in marked contrast to PikC, which converts YC-17 with equal efficiency to methymycin and neomethymycin (19) . CYP154C1 binds YC-17 and narbomycin with similar affinity (K d ϭ 405 and 403 M, respectively), producing type I binding spectra resulting from expulsion of a water molecule from the iron coordination sphere followed by transition of the heme iron to a pentacoordinate high spin state (Fig. 2, A and C) . The similarities in binding characteristics of CYP154C1, while at the same time showing significant substrate specificity toward the two macrolactone ring systems, represent a significant opportunity to explore structure-function relationships within and between other members of the CYP enzyme class.
X-ray Structure Determination of CYP154C1-The growing number of cytochrome P450 structures in the Protein Data Bank (eight are currently available) provides a pool of search models to aid in solving new P450 structures by the molecular replacement technique. However, amino acid sequence diversity of enzymes within the superfamily has limited use of the molecular replacement approach for cytochrome P450 structure determination (49) . Fortunately, the intrinsic heme-iron atom of cytochromes P450 can be used as an anomalous scatterer to facilitate protein structure determination using the multiple anomalous dispersion technique.
CYP154C1 has 37% sequence identity and 51% sequence similarity to the macrolide monooxygenase EryF, the highest homology to date between P450s with reported x-ray structure. However, this similarity is insufficient to successfully use EryF atomic coordinates to find a molecular replacement solution for CYP154C1, even when poorly conserved regions are omitted from the search model. Thus, CYP154C1 is the first cytochrome P450 whose structure has been determined solely by the multiple anomalous dispersion technique using the endogenous heme-iron as an anomalous scatterer. The final model (Tables  I-III) consists of two molecules in an asymmetric unit each bearing a heme group and residues 8 -407, plus three residues from the C-terminal His tag for the first molecule, along with 520 water molecules and eight sulfate ions. Nine residues in the first molecule and three residues in the second molecule were truncated to Ala because of insufficient electron density.
Overall CYP154C1 Crystal Structure-Although P450 monooxygenases have been studied extensively by x-ray crystallography, new superfamily members continue to reveal structural features as yet unpredictable from primary sequence. SCHEME 1. Reactions catalyzed by cytochromes P450 EryF and PikC.
FIG. 2. Substrate binding and catalytic activity of CYP154C1.
A, type I binding spectra resulting from CYP154C1 titration with increasing concentrations of YC-17 or narbomycin ranging from 50 to 390 M. B, linearization of the titration data in the form of S 0 /⌬A versus S 0 plot. C, thin layer chromatography analysis of products of the catalytic conversion of YC-17 or narbomycin by PikC and CYP154C1. MM is for methymycin, NMM is for neomethymycin, NBM is for narbomycin, and PKM is for pikromycin.
Despite relatively high homology to EryF, the three-dimensional appearance of the substrate-free CYP154C1 is quite distinct from substrate/inhibitor bound EryF. CYP154C1 appears to be separated along the interface between the ␤-sheet and ␣-helical domains from the distal surface all the way down to the heme ( Fig. 3A; see also Fig. 6 ). The two domains remain separated by a slit about 10 Å wide without additional stabilizing forces. Despite the distinct packing environment in the crystal, two molecules in an asymmetric unit show minor deviations (root mean square deviation of 0.3 Å as calculated using an algorithm implemented in SWISS PDB VIEWER (50)) in the major part of the structure, whereas more significant deviations up to 1.8 Å are observed in the FG region (blue in Fig. 3A) . Repositioning of the FG loop results in slightly more open access to the active site in the one molecule compared with the second.
The open conformation in CYP154C1 is achieved by relocation of certain secondary structure elements constituting the common P450 fold, as well as being due to a novel ␤-strand unique to CYP154C1. As seen from of the alignment (Fig. 1A) and from stereo views of the structure (Fig. 3) , ␤-sheet 1 in CYP154C1 consists of six strands instead of the five observed in EryF and other P450s. The new strand (indicated for CYP154C1 as ␤1-1 (Fig. 1A) ) precedes the invariant helix A. At residues Pro 14 -Phe 15 the polypeptide chain makes a 180°turn so that the A helix runs in a direction anti-parallel to the ␤1-1 strand. The result of this new arrangement is absence of the AЈ 3 10 helix present in EryF or a loop preceding the A helix in some other P450s that normally contribute to interactions between the ␣-helical and ␤-sheet domains. In the ␣-helical domain, significant dislocation of the F, G (blue in Fig. 3A) , and BЈ (violet) helices relative to their positions in substrate-bound EryF (green in Fig. 3B ) occurs. The F and G helices are translocated away from the distal and toward the proximal surface by about one ␣-helical turn. Together with the shorter length of the G helix in CYP154C1 and the FG loop being open compared with EryF, a significant separation between the two protein domains is achieved. Additionally, the BЈ helix in CYP154C1 is repositioned relative to its EryF counterpart so that it becomes almost parallel to the G helix (Fig. 3B) . These two helices complete the formation of an opening, which we believe is a substrate-binding site in CYP154C1.
An important issue regarding the open conformation of CYP154C1 is whether its presence is due to the empty active site pocket. If so, CYP154C1 might oscillate between open/ closed conformations triggered by substrate binding/product release. Conformational changes leading to closure of the active site entrance caused by substrate binding have been demonstrated previously for P450BM3 (51, 52) . S. coelicolor A3(2) CYP154C1 is the second P450 (after mycobacterial CYP51 (53)) whose active site is accessible from the surface in substratefree form. Obtaining structures for P450s in substrate-free and substrate-bound forms are expected to address the complex conformational changes that occur when substrate binds, and following hydroxylation the product is released from the enzyme. These dynamic affects could account for the open structure of substrate-free CYP154C1 and the closed structure of substrate-bound EryF.
Analysis of the Putative CYP154C1 Substrate-binding SiteThe putative CYP154C1 substrate-binding site in the absence of substrate is shaped as a cleft open from the distal surface, with both walls built by hydrophobic residues (Fig. 4) . The back side of the cleft is lined by polar residues and has negative potential because of Asp 398 , the only charged residue residing in the substrate-binding site. The left cleft wall is predominantly built by the residues from the BC loop, whereas the right wall is comprised of residues from the FG region and the I helix (Fig. 4) .
Sequence alignment of CYP154C1 with other highly related monooxygenases shows variation in the BC loop region (enclosed in box in Fig. 1A) . Significantly, this region is two residues shorter in CYP154C1 than in EryF and is substantially shorter (11 residues) in PikC that has broad substrate specificity having ability to hydroxylate both 12-and 14-membered ring macrolide antibiotics. It is worth noting that sequence alignment of CYP154C1 with CYP105C1 from Streptomyces griseus also shows significant shortening of the BC loop (20 residues shorter in CYP105C1 and five residues shorter in three other family members) (Fig. 1B) . It seems likely that the shortened BC loop would allow more space above the heme plane and confer more freedom to accommodate substrates of variable size. This is consistent with the biological function of monooxygenases with broad substrate specificity, including PikC and xenobiotic functionalizing enzymes, which may be inherently more flexible.
A water molecule bound to the iron in the sixth coordination site (W1 in Fig. 5 ) was modeled into electron density in the active site of each molecule in an asymmetric unit. Although iron-bound water has a relatively high temperature factor, 40.1 Å 2 with the occupancy of 1.0 in both molecules, omitting this water from the model results in appearance of extra electron density in a F o Ϫ F c map (dark blue in Fig. 5 ). The iron-oxygen distances in CYP154C1 are refined to 2.42 and 2.54 Å for the two molecules, which is considerably longer than the 2.28 Å observed in substrate-free P450cam (54) . High B-factors for water at the sixth ligand position are likely a result of partial occupancy of this site. The relatively long iron-oxygen distance also indicates that this bond is weakened in CYP154C1 compared with P450cam.
The I Helix Motif in CYP154C1-Water in the sixth coordination site (W1) is hydrogen-bonded to the carbonyl oxygen of Ala 242 (with the distances 2.65 and 2.78 Å in both molecules), which in turn is hydrogen bonded to the side chain of Thr 246 occupying the n ϩ 4 position along the same face of the I helix (Fig. 5) 247 (residue numbers are according to CYP154C1). To a large degree the motif conservation seems to be determined by the position of the I helix relative to the heme plane. The I helix is positioned so that residues 242 and 246 face the heme plane to the exclusion of bulky side chains because of space constraints (Fig.  5) . Because of the small size of these side chains, the I helix approaches near the heme plane and enables a carbonyl oxygen of residue 242 (usually Ala, sometimes Gly) to hydrogen bond a water molecule bound to the heme iron. This interaction violates the hydrogen bonding pattern and the geometry of the I helix. To compensate for missing helical hydrogen bonds, the hydroxyl of Thr 246 (or Ser in many P450s) hydrogen bonds with the carbonyl oxygen of Ala 242 , whereas the hydroxyl of Thr 247 hydrogen bonds to the carbonyl oxygen of Gly 243 . This unconventional ␣-helix hydrogen bonding pattern is observed in the I helix of most structurally defined CYPs (53) .
Gly in position 243 is the most highly conserved within the I helix motif, and we believe is related to the molecular dynamics of P450 molecules. Gly confers flexibility to the I helix, which might allow the I helix water binding cleft (Fig. 5) to adjust its size expelling or accepting a water molecule (55) and also allow the I helix N terminus to perform swinging motions in response to substrate or inhibitor binding in the active site (52, 53, 56) . Conservation of residue functionalities in positions 245, partially 246, and perhaps 247 is likely due to mechanistic reasons for electron and/or proton transfer and for oxygen activation (57) (58) (59) . Apparently, structural reasons dominate conservation of this motif because positions 242, 243, and 246 are never occupied by residues with bulky side chains, whereas functionalities of residues in 245, 246, and 247 alternate. Whether these variations correlate with reaction mechanism is unknown because most P450s have not been studied in sufficient detail to address this question.
The CYP154C1 structure illustrates that functional diversity within the cytochrome P450 family arises from the structural diversity of a few externally positioned elements: the F and G helices with the FG loop in between and the highly variable BЈ helix, whereas the oxygen scission site remains largely intact. Relocation of the structural elements allows an almost endless number of configurations for P450 substratebinding sites, particularly in the absence of substrate, and might be a serious obstacle in attempts to predict new cytochrome P450 structures based on homology modeling approaches.
Surface Electrostatic Potential of CYP154C1-Electrostatic potential distribution shows the presence of a cationic patch on the proximal surface of CYP154C1 (Fig. 6) , the region that has been implicated in redox partner interactions in P450s (60) . A similar cationic patch is present on the surface of EryF, although it has a larger dipole moment (694 versus 305 Debye in CYP154C1) pointed in a different direction (Fig. 6) . The dipole vector of CYP154C1 points directly in the middle of the patch on a proximal surface almost perpendicular to the heme plane, whereas the dipole vector of EryF is strongly inclined toward the C and CЈ helices. A key landmark of the proximal surfaces of both CYP154C1 and EryF is a protruding Arg 344 (Arg 339 in FIG. 4 . Putative substrate-binding site of CYP154C1. For a better view of the cleft entrance, the CYP154C1 molecule in Fig. 3 was rotated toward the viewer approximately along the horizontal axis in the plane of the drawing. Residues building the left wall of the binding site cleft are from the BC loop (violet), and residues building the right wall are from the FG region (blue) and the I helix (green). Residues lining the back side of the cleft (gray) are from the last turn within ␤-sheet 3 and from the junction between the K helix and the strand ␤1-5.
EryF) coming from the region known as the meander. Together with other positively charged residues that form similar patterns on the proximal surfaces of both CYP154C1 and EryF (Fig. 6) , the prominent Arg might play a role in anchoring the electron donor on the cationic patch.
Biological Implications-This effort represents the first structural analysis of S. coelicolor CYP enzymes and is expected to provide information on hydroxylation patterns of endogenous as well as exogenous substrates. Cytochrome P450 monooxygenases from Streptomyces catalyze site-specific oxidations of the precursors to many macrolide antibiotics and degrade a wide range of xenobiotic compounds. Use of Streptomyces in the production of natural products of pharmaceutical importance as well as in bioremediation technologies provides an important incentive to identify native enzymes and engineer novel monooxygenases with activities toward alternative substrates. Together with the opportunity to manipulate entire biosynthetic gene clusters, it allows design of biosynthetic pathways giving rise to novel polyketides and other natural product structures. CYP154C1 is the first three-dimensional structure for P450 monooxygenase with activity toward polyketides of diverse structures and will contribute to understanding the molecular basis for the specificity of oxidative tailoring in macrolide antibiotic biosynthesis, as well as in development of approaches that lead to fully elaborated and biologically active macrolide structures. Red was also used for the heme iron. Two water molecules in the active site are represented by the red spheres: W1 is for water in the sixth heme ligand position, and W2 is for water in the water-binding cleft of the I helix. Fragments of the 2F o Ϫ F c electron density composite omit map are contoured at 1.0 (cyan) and 2.5 (red). Fragment of the F o Ϫ F c electron density map generated with W1 omitted is contoured at 1.5 (dark blue).
FIG. 6.
Surface electrostatic potential of CYP154C1 and EryF. The deepest shades of red and blue correspond to potentials of Ϫ22.6 and 27.2 kcal, respectively, whereas neutral points are white. Heme partially seen through the cleft is green. Cyan three-dimensional vectors show the direction and relative size of molecular dipoles for CYP154C1 and EryF.
